To quantify the magnitude of the association between maternal diabetes (DM) and severe neonatal morbidity and mortality. STUDY DESIGN: Retrospective cohort study of women with a nonanomalous singleton who delivered between 24 0/7 and 41 6/7 weeks' gestation from two large U.S. databases: MFMU Cesarean Registry (1999-2002 and Consortium on Safe Labor (2002)(2003)(2004)(2005)(2006)(2007)(2008). The primary exposure was DM status: pregestational type 1 or 2 DM vs GDM vs no DM. The primary outcome was a composite of severe neonatal morbidity including RDS, mechanical ventilation, NEC, grade 3 or 4 IVH, and neonatal death. Multivariable logistic regression was used to estimate the association between DM and severe neonatal morbidity with three main comparisons: pregestational DM vs no DM, pregestational DM vs GDM, and GDM vs no DM. RESULTS: 196,397 subjects met inclusion criteria: 63,929 (32.6%) from the Cesarean Section Registry and 132,468 (67.5%) from the Consortium on Safe Labor. Among these, 10,564 (5.4%) had GDM and 3,008 (1.5%) had pregestational DM. Compared to non-diabetic women, those with GDM and pregestational DM were older, had higher BMI, more medical comorbidities (chronic hypertension, cardiac disease, renal disease), more pregnancy complications (gestational hypertension or preeclampsia, cesarean, LGA neonate), and were more likely to be delivered at an earlier gestational age (Table 1) . Pregestational DM was associated with higher adjusted odds of severe neonatal morbidity, compared to no DM and compared to GDM (Table 2 ). In contrast, there was no significant association between GDM and severe neonatal morbidity, compared to no DM. Similar relationships were observed for certain components of this composite, RDS and mechanical ventilation, as well as NICU admission. In addition, GDM was associated with a higher adjusted odds of NICU admission, compared to no DM. Using the final multivariable logistic regression model, the estimated probability of severe neonatal morbidity was 6.7% (95% CI 6.6-6.8%) among women without DM, 9.7% (95% CI 9.3-10.0%) among women with GDM, and 13.7% (95% CI 12.8-14.6%) among women with pregestational DM. CONCLUSION: Neonates born to women with pregestational DM were more likely to have severe morbidity and mortality, compared to those without DM and to those with GDM. Differences in severe neonatal morbidity and mortality were not appreciated for women with GDM compared to those without DM, however, there was an association with NICU admission.
